Table 5. miRNA Regulating WEE1.
S. no. | year | miRNA | cancer cells | refs |
---|---|---|---|---|
1 | 2009 | miR-195 | human embryonic stem cells (hESCs) | (173) |
2 | 2010 | miR-516a-3p | pituitary adenomas | (174) |
miR-128a | ||||
miR-155 | ||||
3 | 2011 | miR-17 | unrestricted somatic stem cells from human cord blood (USSC) | (175) |
miR-20a | ||||
miR-106b | ||||
4 | 2011 | miR-128 | glioma cells | (176) |
5 | 2013 | miR-497 | neuroblastoma cells | (177) |
6 | 2013 | miR-424 | renal cancer cells | (178) |
7 | 2013 | miR-381 | ||
8 | 2015 | miR-17-92 cluster | leukemia | (179) |
9 | 2016 | miR-219-5p | RAW264.7 cells | (180) |
10 | 2017 | miR-503 | laryngeal carcinoma | (181) |
11 | 2017 | miR-194 | laryngeal squamous cell carcinoma (LSCC) | (182) |
12 | 2019 | miR-526b-3p | glioma cells | (183) |
13 | 2019 | miR-384 | laryngeal carcinoma cells | (166) |
14 | 2019 | miR-101-3P | HCC | (167) |
15 | 2020 | miR-140-5p | NSCLC | (165) |
16 | 2020 | miR-105-5p | glioma cells | (163) |
17 | 2021 | miR-16-5p | NSCLC | (184) |
18 | 2022 | miR-138-5P | glioma cells | (185) |